Breast screening review - A radiologist's perspective

British Journal of Radiology

Volumn 85, Issue 1015, 2012, Pages 845-847

  Michell, Michael J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; GENETIC RISK; GENETIC SCREENING; HUMAN; IMAGE QUALITY; MAMMOGRAPHY; META ANALYSIS (TOPIC); NORTH AMERICA; NOTE; NUCLEAR MAGNETIC RESONANCE; RADIOLOGIST; SCIENTIFIC LITERATURE; SURVIVAL RATE; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HEALTH EDUCATION; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PHYSICIAN'S ROLE; PROGRAM EVALUATION; RADIOLOGY; RISK ASSESSMENT;

EID: 84863676485     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/21332901     Document Type: Note

References (37)

1. Forrest P. Department of Health and Social Security. Breast cancer screening, Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London, UK: Her Majesty's Stationery Office; 1986.
2. Patnick J. NHS Cancer Screening Programmes. NHS Breast Screening Programme Annual Review 2010, Overcoming Barriers. Sheffield, UK; 2010.
3. Moser K, Sellars S, Wheaton M, Cooke J, Duncan A, Maxwell A, et al. Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen 2011;18:96-102.
4. Department of Health. Cancer reform strategy. London, UK; 2007.
5. Smyth C. Women in breast cancer dilemma as experts disagree over screening. The Times. 26 October 2011, pp. 8-9.
6. Boseley S. NHS breast screening is leading to needless treatment, say scientists. The Guardian. 12 October 2011. Available from: http://www.guardian. co.uk/society/2011/oct/12/nhs-breast-screening-treatment?INTCMP5SRCH
7. McPherson K. Should we screen for breast cancer? BMJ 2010;341:233-5.
8. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411.
9. Jorgensen KJ, Keen JD, Gotzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 2011;260:621-7.
10. Bewley S. The NHS breast screening programme needs an independent review. BMJ 2011;343:d6894.
11. Raftery J, Chorozoglou M. Possible net harms of breast cancer screening: updated modelling of Forrest report. BMJ 2011;343:d7627.
12. Hackshaw A. Benefits and harms of mammography screening. BMJ 2012;344:d8279.
13. Gotzsche PC, Jorgensen KJ. The breast screening programme and misinforming the public. J R Soc Med 2011;104:361-9.
14. Smyth C. Women misled over breast screening. The Times. 1 September 2011, pp. 3.
15. Richards M. An independent review is under way. BMJ 2011;343:d6843.
16. Vainio H, Bianchini F. IARC handbooks of cancer prevention. Breast cancer screening. Lyon, France: IARCPress; 2002.
17. Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, et al. The Swedish two-county trial twenty years later. Radiol Clin North Am 2000;38:625-51.
18. Nystrom L, Anderson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. (Pubitemid 34246378)
19. Tabar L, Yen MF, Vitak B, Chen THH, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20 year follow up before and after introduction to screening. Lancet 2003;361:1405-10. (Pubitemid 36515039)
20. Tabar L, Vitak B, Chen THH, Yen AMF, Cohen A, Tot T, et al. Swedish two county trial: impact of mammographic screening in breast cancer mortality during three decades. Radiology 2011;260:658-63.
21. Cancerresearchuk.org. Breast cancer - UK survival statistics. [cited 24 February 2012] Available from: http://info.cancerresearchuk.org/cancerstats/ types/breast/survival
22. th October 2009. [cited 24 February 2012] Available from: http://info.cancerresearchuk.org/cancerstats/types/breast/mortality/
23. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Hery C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.
24. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995;345:1265-70.
25. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92. (Pubitemid 41549890)
26. National Institute for Clinical Excellence. Early and locally advanced breast cancer. Diagnosis and treatment. Clinical guideline 80. London: National Institute for Clinical Excellence; 2009.
27. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106:416-22. (Pubitemid 36870406)
28. Richards M. EUROCARE-4 studies bring new data on cancer survival. Lancet Oncol 2007;8:752.
29. NHS Cancer Screening Programmes. Screening for breast cancer in England: past and future. Advisory Committee on breast cancer screening. NHSBSP publication No 61. Sheffield, UK; 2006.
30. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, et al. Absolute numbers of lives saved and over diagnosis in breast cancer screening, from a randomised trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30.
31. Kopans DB, Smith RA, Duffy SW. Mammographic screening and overdiagnosis. Radiology 2011;260:616-20.
32. Michell MJ. The breast. In: Sutton D. Textbook of radiology and imaging. London, UK: Churchill Livingstone; 2003. pp. 1451-88.
33. O'Flynn EAM, Morel JC, Gonzalez J, Dutt N, Evans D, Wasan R, et al. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy. Clin Radiol 2009;64:178-83.
34. West Midlands Cancer Intelligence Unit. The Sloane Project - UK prospective audit of screen-detected non-invasive carcinomas and atypical hyperplasia of the breast: Progress Report 2008/2009 and 2009/2010. Wakefield, UK; 2010.
35. Francis A. Association of breast surgery, Yearbook 2012. The Association of Breast Surgery at The Royal College of Surgeons. London, UK; 2012. pp. 70-1.
36. NHS Cancer Screening Programmes. NHS breast screening the facts. London, UK; 2011.
37. Baum M, Thornton H, Getzsche PC, Bewley S, Jørgensen KJ, Barratt A, et al. Breast cancer awareness month: still awaiting screening facts. BMJ 2010;341:c6152.